HNN3.0
Register
Register
Register

Project cooperationUpdated on 26 January 2026

Project Cooperation - Microbiome research

Project Manager at InnovITech Kft.

Budapest, Hungary

About

We are building a multidisciplinary consortium and are currently looking for partners to join a collaborative microbiome research project focused on delivering reproducible, clinically relevant insights into the role of the human microbiome in health and disease. The project will integrate high-quality clinical cohorts and harmonised sample workflows with state-of-the-art microbiome and host multi‑omics, supported by robust bioinformatics to identify and validate biomarkers, mechanistic pathways, and intervention targets.

We welcome cooperation with complementary organisations, including clinical sites (patient recruitment, phenotyping, biobanking), academic microbiome laboratories (wet-lab profiling, functional interpretation), data/bioinformatics teams (pipelines, integration, statistical validation), and industry/SME partners (translation, implementation, and exploitation). The intended collaboration model reflects common EU microbiome project structures using coordinated work packages for cohort harmonisation, omics generation, integrated analysis, validation, ethics/data governance, dissemination, and project management, enabling efficient cross-site execution and comparable results.

Topic

  • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Organisation

InnovITech Kft.

Company (SME)

Budapest, Hungary

Similar opportunities

  • Project cooperation

    Microbiome research in health and disease

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Leen Assil Companioni

    Head of Public Funding at CBmed GmbH

    Graz, Austria

  • Project cooperation

    Multi-omics (AI) Biomarker & Predictive Model Co-Development for Precision Medicine

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Miguel Angel Andrés Gasco

    CEO & Co-Founder at Nexyra Advanced Research

    Madrid, Spain

  • Project cooperation

    Microbiome-based biomarkers associated with environmental exposures, lifestyle and health outcomes

    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Florence Buytaers

    Scientist at Sciensano

    Brussels, Belgium